Nov 1 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2019 Sep 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.32 30.48 65.00
(-0.5 pct) (-6.0 pct) (+5.1 pct)
Operating 1.74 2.07 5.00
(-16.0 pct) (-13.5 pct) (+33.8 pct)
Recurring 1.63 1.91 5.00
(-15.0 pct) (-24.5 pct) (+51.7 pct)
Net 1.23 2.28 3.80
(-46.0 pct) (+7.2 pct) (+10.0 pct)
EPS 26.16 yen 45.40 yen 81.34 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T